Pharma IQ Members


Soren Skovlund
Søren Skovlund is director of global patient research, advocacy and support in Novo Nordisk and oversees the global DAWN (Diabetes Attitudes Wishes & Needs) study led by Novo Nordisk. In this interview he joins Pharma IQ, to discuss best practice approaches to patient education and self-management....Full Article »